Boots has bucked global economic challenges after reporting its 17th consecutive quarter of sales growth in Q3 2025.
Total sales rose 5% during the quarter, as a boom in demand for beauty and wellness products benefited the Walgreens Boots Alliance (WBA)-owned UK health and beauty retailer.
Comparable retail sales increased 6% on a constant currency basis compared with the previous year.
The biggest uplift came from the retailer’s online channel, with boots.com sales growing 18.7% in Q3.
This represented 17% of Boots’ total retail sales.
The strong performance from Boots in the UK contributed to an increase in total sales at WBA of 7.2% to US$39bn.
WBA has faced challenges across its US pharmacy operations in recent years, and is exploring a turnaround strategy for the business.
The company revealed in October 2024 it was set to shutter 1,200 Walgreens stores in the US over the next three years after its losses widened.
“Third quarter results reflect continued improvement in our US health care segment and benefits from our cost savings initiatives, while we continued to see weakness in our US front-end sales,” said WBA CEO Tim Wentworth.
“We remain focused on our turnaround plan, which will require time, disciplined focus and a balanced approach to manage future cash needs with investments necessary to navigate an evolving pharmacy and retail environment.”
The financial update follows Boots’ CMO Pete Markey stepping away from the company after more than four-and-a-half years in the role.
Markey joined the UK health and beauty retailer in 2021 and is said to have played a key role in leading a widespread data-driven overhaul.
WBA was acquired in a US$10bn deal by Sycamore Partners in March, which has taken the US multinational holding company private.